Tianjin Eye Hospital
Tianjin, 300020, China
NCT Number: NCT05956704
In this study, we intend to enroll orthokeratology subjects aged 8-18 years old with binocular myopia up to and including -4.00 D. They were randomly selected to wear both orthokeratology of different designs, one with an aspheric wide inversion zone design in the optical zone and the other with a traditional spherical curved segment design, and to investigate the differences between these two lenses in terms of their effectiveness in myopia retardation, defocus, and aberration.
Looking for future studies?
Notify Me8 year–18 year
All sexes
Interventional
Not applicable
Tianjin, 300020, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An orthokeratology lens with an altered optical zone design is designed for an aspherical wide inversion arc in the optical zone
Subjects wore the orthokeratology with traditional spherical design in the optical zone
Time frame: The change of baseline and 1years
Axial length was measured with a biometer
Tianjin Eye Hospital
Other
The Effectiveness and Safety of Different Design of Orthokeratology Lenses to Reduce Myopia Growth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsNCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial Details